The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Aadi Bioscience Inc | Common | 00032Q104 | 6,456,277 | 509,572 | SH | SOLE | 509,572 | 0 | 0 | |||
Alpine Immune Sciences Inc | Common | 02083G100 | 10,475,754 | 914,913 | SH | SOLE | 914,913 | 0 | 0 | |||
Aclaris Therapeutics, Inc. | Common | 00461U105 | 6,155,622 | 898,631 | SH | SOLE | 898,631 | 0 | 0 | |||
Aligos Therapeutics Inc | Common | 01626L105 | 2,649,631 | 3,547,030 | SH | SOLE | 3,547,030 | 0 | 0 | |||
Allakos Inc | Common | 01671P100 | 6,782,760 | 2,988,000 | SH | SOLE | 2,988,000 | 0 | 0 | |||
ALX Oncology Holdings Inc | Common | 00166B105 | 20,256,230 | 4,220,048 | SH | SOLE | 4,220,048 | 0 | 0 | |||
Amyris, Inc | Common | 03236M200 | 465,050 | 7,750,828 | SH | SOLE | 7,750,828 | 0 | 0 | |||
Apogee Therapeutics Inc | Common | 03770N101 | 8,520,000 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | |||
Arcellx Inc. | Common | 03940C100 | 18,067,912 | 503,565 | SH | SOLE | 503,565 | 0 | 0 | |||
Arrowhead Pharmaceuticals Inc | Common | 04280A100 | 3,692,234 | 137,411 | SH | SOLE | 137,411 | 0 | 0 | |||
Aslan Pharmaceuticals Ltd | ADS | 04522R101 | 1,068,181 | 568,182 | SH | SOLE | 568,182 | 0 | 0 | |||
Astria Therapeutics Inc | Common | 04635X102 | 12,541,745 | 1,681,199 | SH | SOLE | 1,681,199 | 0 | 0 | |||
Avadel Pharmaceuticals PLC | ADR | 05337M104 | 42,193,208 | 4,096,428 | SH | SOLE | 4,096,428 | 0 | 0 | |||
BioAtla Inc | Common | 09077B104 | 908,108 | 534,181 | SH | SOLE | 534,181 | 0 | 0 | |||
Bolt Therapeutics Inc | Common | 097702104 | 4,026,143 | 3,871,291 | SH | SOLE | 3,871,291 | 0 | 0 | |||
Clene Inc | Common | 185634102 | 1,396,738 | 2,645,338 | SH | SOLE | 2,645,338 | 0 | 0 | |||
Codexis, Inc | Common | 192005106 | 733,592 | 388,144 | SH | SOLE | 388,144 | 0 | 0 | |||
Cogent Biosciences Inc | Common | 19240Q201 | 21,888,175 | 2,244,941 | SH | SOLE | 2,244,941 | 0 | 0 | |||
Compass Pathway PLC | SPONSORED ADS | 20451W101 | 11,899,200 | 1,608,000 | SH | SOLE | 1,608,000 | 0 | 0 | |||
Compass Therapeutics Inc | Common | 20454B104 | 7,005,365 | 3,556,023 | SH | SOLE | 3,556,023 | 0 | 0 | |||
Crinetics Pharmaceuticals Inc | Common | 22663K107 | 10,409,000 | 350,000 | SH | SOLE | 350,000 | 0 | 0 | |||
DBV Technologies SA | Sponsored ADR | 23306J101 | 3,684,070 | 2,708,875 | SH | SOLE | 2,708,875 | 0 | 0 | |||
Delcath Systems, Inc. | Common | 24661P807 | 7,513,524 | 1,855,191 | SH | SOLE | 1,855,191 | 0 | 0 | |||
Dyne Therapeutics Inc | Common | 26818M108 | 9,274,819 | 1,035,136 | SH | SOLE | 1,035,136 | 0 | 0 | |||
Fulcrum Therapeutics Inc | Common | 359616109 | 2,308,800 | 520,000 | SH | SOLE | 520,000 | 0 | 0 | |||
Genetron Holdings Ltd | ADS | 37186H100 | 104,570,306 | 8,124,174 | SH | SOLE | 8,124,174 | 0 | 0 | |||
Geron Corp | Common | 374163103 | 35,032,224 | 16,524,634 | SH | SOLE | 16,524,634 | 0 | 0 | |||
Gracell Biotechnologies Inc | SPONSORED ADS | 38406L103 | 31,337,695 | 10,881,144 | SH | SOLE | 10,881,144 | 0 | 0 | |||
Harmony Biosciences Holdings Inc | Common | 413197104 | 85,406,714 | 2,606,247 | SH | SOLE | 2,606,247 | 0 | 0 | |||
Homology Medicines, Inc. | Common | 438083107 | 432,980 | 370,068 | SH | SOLE | 370,068 | 0 | 0 | |||
Icosavax, Inc. | Common | 45114M109 | 13,210,402 | 1,704,568 | SH | SOLE | 1,704,568 | 0 | 0 | |||
Impel NeuroPharma Inc | Common | 45258K109 | 1,240,459 | 2,884,789 | SH | SOLE | 2,884,789 | 0 | 0 | |||
Instil Bio Inc | Common | 45783C101 | 5,344,345 | 12,486,787 | SH | SOLE | 12,486,787 | 0 | 0 | |||
IO Biotech Inc | Common | 449778109 | 8,704,549 | 6,173,439 | SH | SOLE | 6,173,439 | 0 | 0 | |||
Iovance Biotherapeutics Inc | Common | 462260100 | 2,980,509 | 655,057 | SH | SOLE | 655,057 | 0 | 0 | |||
KalVista Pharmaceuticals Inc. | Common | 483497103 | 8,243,357 | 856,008 | SH | SOLE | 856,008 | 0 | 0 | |||
Olema Pharmaceuticals Inc | Common | 68062P106 | 23,140,244 | 1,873,704 | SH | SOLE | 1,873,704 | 0 | 0 | |||
Oric Pharmaceuticals Inc | Common | 68622P109 | 4,706,561 | 777,944 | SH | SOLE | 777,944 | 0 | 0 | |||
Precision Biosciences Inc | Common | 74019P108 | 47,869 | 140,255 | SH | SOLE | 140,255 | 0 | 0 | |||
Rayzebio Inc | Common | 75525N107 | 14,065,387 | 633,576 | SH | SOLE | 633,576 | 0 | 0 | |||
Rezolute Inc | Common | 76200L309 | 639,459 | 484,439 | SH | SOLE | 484,439 | 0 | 0 | |||
Savara Inc | Common | 805111101 | 7,232,459 | 1,913,349 | SH | SOLE | 1,913,349 | 0 | 0 | |||
Sera Prognostics Inc | Common | 81749D107 | 3,452,180 | 1,856,011 | SH | SOLE | 1,856,011 | 0 | 0 | |||
Sinovac Biotech Ltd. | SHS | P8696W104 | 38,173,000 | 5,900,000 | SH | SOLE | 5,900,000 | 0 | 0 | |||
Soleno Therapeutics Inc | Common | 834203309 | 94,523,274 | 3,203,093 | SH | SOLE | 3,203,093 | 0 | 0 | |||
Tarsus Pharmaceuticals Inc | Common | 87650L103 | 40,199,294 | 2,262,200 | SH | SOLE | 2,262,200 | 0 | 0 | |||
Terns Pharmaceuticals Inc | Common | 880881107 | 33,489,700 | 6,657,992 | SH | SOLE | 6,657,992 | 0 | 0 | |||
Unicycive Therapeutics | Common | 90466Y103 | 2,984,331 | 3,470,152 | SH | SOLE | 3,470,152 | 0 | 0 | |||
Ventyx Biosciences Inc | Common | 92332V107 | 14,658,665 | 422,075 | SH | SOLE | 422,075 | 0 | 0 | |||
Verastem Inc | Common | 92337C203 | 12,507,688 | 1,538,461 | SH | SOLE | 1,538,461 | 0 | 0 | |||
Verona Pharma PLC | ADS | 925050106 | 69,273,663 | 4,249,918 | SH | SOLE | 4,249,918 | 0 | 0 | |||
Viridian Therapeutics Inc | Common | 92790C104 | 25,743,695 | 1,678,207 | SH | SOLE | 1,678,207 | 0 | 0 | |||
Zai Lab Ltd ADR | ADR | 98887Q104 | 11,051,472 | 454,606 | SH | SOLE | 454,606 | 0 | 0 |